CIK 0000811641 · Non-accelerated filer<br>Smaller reporting company
IMMUCELL CORP /DE/
Sign in to watch- Ticker
- ICCC
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010382980
- Phone
- 2078782770
- Business address
- 56 EVERGREEN DR, PORTLAND, ME, 04103
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-07 | Tomsche David Scott Director | Returned to the company | +53 | $8.18 | $434 | 90,384 |
| 2022-06-02 | Tomsche David Scott Director | Returned to the company | +112 | $8.20 | $918 | 90,331 |
| 2022-06-01 | Tomsche David Scott Director | Returned to the company | +100 | $8.27 | $827 | 89,219 |
| 2022-06-01 | Tomsche David Scott Director | Returned to the company | +700 | $8.25 | $6K | 89,919 |
| 2022-06-01 | Tomsche David Scott Director | Returned to the company | +300 | $8.23 | $2K | 90,219 |
| 2022-05-17 | Tomsche David Scott Director | Returned to the company | +3,400 | $8.37 | $28K | 89,119 |
| 2022-05-17 | Tomsche David Scott Director | Returned to the company | +3,400 | $8.37 | $28K | 104,119 |
| 2022-05-16 | Tomsche David Scott Director | Returned to the company | +200 | $8.35 | $2K | 85,719 |
| 2022-05-16 | Tomsche David Scott Director | Returned to the company | +200 | $8.35 | $2K | 100,719 |
| 2022-03-09 | CRABB JOSEPH H Former VP and CSO | Returned to the company | +1,000 | $5.84 | $6K | 142,845 |
| 2022-01-31 | Brockmann Bobbi Jo VP of Sales & Marketing | Grant or award · Incentive Stock Options (Right to buy) | +18,000 | $8.15 | $147K | 0 |
| 2022-01-31 | BRIGHAM MICHAEL F President & CEO | Grant or award · Incentive Stock Options (Right to buy) | +1,000 | $8.15 | $8K | 1,000 |
| 2022-01-31 | Williams Elizabeth Luttrell VP of Manufacturing Operations | Grant or award · Incentive Stock Options (Right to buy) | +1,000 | $8.15 | $8K | 1,000 |
| 2021-06-17 | Basse Gloria F Director | Grant or award · Incentive Stock Options (Right to buy) | +10,000 | $10.04 | $100K | 10,000 |
| 2021-06-17 | Rosgen Steven T. Director | Grant or award · Incentive Stock Options (Right to buy) | +10,000 | $10.04 | $100K | 10,000 |
| 2021-06-17 | Cunningham David Director | Grant or award · Incentive Stock Options (Right to buy) | +10,000 | $10.04 | $100K | 10,000 |
| 2021-06-17 | Tomsche David Scott Director | Grant or award · Incentive Stock Options (Right to buy) | +10,000 | $10.04 | $100K | 10,000 |
| 2021-06-17 | Wainman Paul R Director | Grant or award · Incentive Stock Options (Right to buy) | +10,000 | $10.04 | $100K | 10,000 |
| 2021-06-03 | ROTHSCHILD JONATHAN E Director | Grant or award | +3,845 | $7.08 | $27K | 514,003 |
| 2021-06-03 | ROTHSCHILD JONATHAN E Director | Returned to the company · Incentive Stock Options (Right to buy) | −11,155 | $9.52 | $106K | 0 |
Page 6 of 11 · 209 trades